ArticleWorld journal of diabetes2025
Reasons for discontinuing tirzepatide in randomized controlled trials: A systematic review and meta-analysis.
Abul Bashar Mohammad Kamrul-Hasan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it